Hydrogen peroxide is an ubiquitous metabolite in living systems, produced at increased levels in a variety of pathological situations. Therefore suppressing or at least controlling H2O2 production is important. Catalase enzymes can convert hydrogen peroxide into water and dioxygen and a similar role can be played by transition metal ions or some radiopharmaceuticals. (1) TcO − 4 , (2) Tc-99m mercaptoacetyltriglycine (MAG3) and (3) Tc-99m methoxyisobutylisonitrile (MIBI) were each tested for their ability to catalyse the disproportionation of hydrogen peroxide in the presence of the added base imidazole. It was found that (2) and (3) exhibit acceptable catalase-like activity compared to the Tc-99m pertechnetate.
Introduction
Most of the single-photon tomography procedures in nuclear medicine involve Tc-99m source. As diagnostic procedures should permit activity levels not leading to radiation deterministic eects, only stochastic risks have to be considered and this stochastic risk of ionizing radiation for an individual patient cannot be evaluated. However, in the case of a population of patients it is as a prerequisite to determine the absorbed dose in all irradiated tissues or organs to be aected by the diagnostic procedure. The accuracy and precision in reference level determination of irradiation largely contributes to the evaluation of the eects of exposure to small or infrequently repeated amounts of radioactive substances, as currently used in diagnostic imaging procedures, on patients' health. However, these eects are not fully evaluated in the European context [1] .
Hydrogen peroxide may cause molecular damage and, over time, cellular dysfunction. It is a byproduct of oxidative metabolism in organisms. This molecular damage will nally accelerate aging and increase the risk of a number of diseases including cancer and diabetes [2] . Catalase transforms hydrogen peroxide (H 2 O 2 ) to water and oxygen. This reaction is a two-electron oxidation/ reduction reaction [3] .
In the presence of multivalent metal ions some synergy between Tc radioactivity and its redox properties might be expected. There are many metal complexes containing iron, manganese, copper, etc. considering their catalase-like activity but in present work, some radiopharmaceuticals i.e. Tc-99m pertechnetate (Tc:7+), Tc-99m mercaptoacetyltriglycine (MAG3) (Tc:5+) and Tc-99m methoxyisobutylisonitrile (MIBI) (Tc:1+) were used compared to other studies. Therefore we tested the radiopharmaceuticals for their ability to catalyse the disproportionation of hydrogen peroxide. * corresponding author; e-mail: ekrcicek@gmail.com Mo, is a radioactive isotope having a half life of 6.007 h. MIBI kit was purchased as freeze-dried commercial kit containing 1.0 mg tetrakis (2-methoxyisobutylisonitrile) copper(I) tetrauoroborate (Monrol AS, Istanbul, Turkey).
Catalase-like activity studies
Volumetric measurements of evolved dioxygen during the reactions of the (1), (2) and (3) with H 2 O 2 were carried out as follows. A 50 cm 3 three-necked round--bottom ask containing 0.30 mL radiopharmaceuticals was placed in a water bath (25 • C). One of the necks was connected to a burette and the others were stoppered by a rubber septum. While the solution was stirred, H 2 O 2 (1.33 mmol, 0.150 mL) was injected into it through the rubber septum using a microsyringe. Volumes of evolved dioxygen were measured at 1 min time intervals by volumometry. In cases where imidazole (50 mg) was added this was introduced into the reaction vessel before the addition of H 2 O 2 .
Results and discussion
The catalase-like activity of the radiopharmaceuticals to disproportionate H 2 O 2 into H 2 O and O 2 was examined at 25
• C by volumetric measurements of evolved dioxygen and experiments were repeated several times to ensure consistency of the results. The time course of the O 2 evolution is shown in Fig. 1, Fig. 2 and Fig. 3 .
According to the catalase-like activity studies of (1), (2) and (3) showed activity for the catalytic decomposition of H 2 O 2 in the presence of added imidazole and the results are summarized in Table. It should be noted that in the absence of the imidazole the radiopharmaceuticals were either inactive or very weak catalysts for disproportionation reaction. On the other hand, the 1H--imidazole base itself caused only a very slight disproportionation of H 2 O 2 . This reaction was greatly enhanced (875) Fig. 1 . Time course of dioxygen evolution in the disproportionation of H2O2 by the (1), (2), and (3); (radiopharmaceuticals) = 0.30 mL, 370 MBq, (H2O2) = 0.15 mL, 298 K. when the radiopharmaceuticals were included in the reaction mixture with the base. It was found that in case of using MAG3 or MIBI bonded Tc-99m pertechnetate, catalase-like activity was increased signicantly where the oxidation state of Tc is (5+) and (1+), respectively. Among radiopharmaceuticals, while the (3) 99mTc-methoxyisobutylisonitrile (MIBI) was the most eective, (1) Tc-99m pertechnetate was the least eective for the catalytic decomposition reaction. The H 2 O 2 disproportionation eciency of the radiopharmaceuticals in the presence 1H-imidazole follows the order: 3 > 2 > 1. In other words the catalytic eciencies of radiopharmaceuticals in the disproportionate reaction decrease while the oxidation state of the Tc increases.
Continuation of the study, catalase-like activity of the (1), (2) and (3) was performed for their three dierent doses 370, 740, and 1110 MBq. 0.9% NaCl solution has negative eects on catalytic activity. As the result of this higher radioactivity has less catalytic activity. Catalytic activities of metals and their complexes are usually explained in terms of either their redox potentials or structures [4, 5] . Redox potential of a metal ion has been considered as one of the critical factors in determining the catalytic activity of the catalyst containing the metal ion towards redox reactions, because the reaction appears to involve a change in the oxidation state of the metal ion during the redox steps. The catalytic activity observed for the radiopharmaceuticals is probably due to favorable redox potentials of the technetium.
